1. Home
  2. PENG vs EVO Comparison

PENG vs EVO Comparison

Compare PENG & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Penguin Solutions Inc. Ordinary Shares

PENG

Penguin Solutions Inc. Ordinary Shares

HOLD

Current Price

$47.43

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.69

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PENG
EVO
Founded
1988
1993
Country
United States
Germany
Employees
2900
4553
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
934.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PENG
EVO
Price
$47.43
$2.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
1
Target Price
$27.78
$7.00
AVG Volume (30 Days)
2.7M
94.1K
Earning Date
04-01-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.55
$1.37
Revenue Next Year
$16.14
$10.05
P/E Ratio
$87.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.04
$2.31
52 Week High
$53.27
$4.80

Technical Indicators

Market Signals
Indicator
PENG
EVO
Relative Strength Index (RSI) 80.38 36.25
Support Level $18.38 $2.32
Resistance Level N/A $3.78
Average True Range (ATR) 3.34 0.09
MACD 1.29 -0.06
Stochastic Oscillator 77.80 6.44

Price Performance

Historical Comparison
PENG
EVO

About PENG Penguin Solutions Inc. Ordinary Shares

Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: